Innovation

Arena Pharmaceuticals has been focused recently on researching and developing a non-opiate for the treatment of gastrointestinal…

The FDA had more than 700 orphan drug designation requests last year. As a result, the FDA recently announced a new pilot program…

As described in a recent opinion article, Health IT Now and the Bipartisan Policy Center convened a work group of organizations…

Thomas P. Stossel, MD, MD (Hon), is a visiting scholar at the American Enterprise Institute and professor emeritus at Harvard…

Late last year, John Jenkins, director of the FDA’s Office of New Drugs told attendees at an event that the decline in new drug…

In an article published in Science Translation Medicine, Disciplined approach to drug discovery and early development, Robert…

At a briefing hosted by the Bipartisan Policy Center (BPC), Senate Health, Education, Labor, and Pensions (HELP) Committee…

Last week, the Senate Health, Education, Labor, and Pensions (HELP) Committee approved a series of seven bills to work…

The Food and Drug Administration's Deputy Commissioner for Medical Products and Tobacco, Robert Califf, recently offered…

Recently, we covered Thomas Stossel, M.D.’s new book, Pharmaphobia: How the Conflict of Interest Myth Undermines American Medical…